Targeted nonviral gene therapy in prostate cancer

References

• International Agency for Research on CancerAll cancers (excluding non-melanoma skin cancer): estimated incidence, mortality and prevalence worldwide in 2012 Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxAccessed November 30, 2017
   Google Scholar
• Cancer ResearchUKProstate cancer incidence statistics2015 Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence/uk-prostate-cancer-incidence-statisticsAccessed November 19, 2017
   Google Scholar
• FreytagSOStrickerHMovsasBKimJHProstate cancer gene therapy clinical trialsMol Ther2007151042105217406342
   PubMed Web of Science ®Google Scholar
• PhilippouYDevHSooriakumaranPDiagnosis and screeningTewariAKWhelanPGrahamJDProstate Cancer: Diagnosis and Clinical ManagementChichesterJohn Wiley & Sons20141633
   Google Scholar
• BagnallPDiagnosis and treatment of prostate cancerNurs Times20141101215
   PubMedGoogle Scholar
• WirthTParkerNYlä-HerttualaSHistory of gene therapyGene201352516216923618815
   PubMed Web of Science ®Google Scholar
• WangWWLiWMaNSteinhoffGNon-viral gene delivery methodsCurr Pharm Biotechnol201314466023437936
   PubMed Web of Science ®Google Scholar
• MaGShimadaHHiroshimaKTadaYSuzukiNTagawaMGene medicine for cancer treatment: commercially available medicine and accumulated clinical data in ChinaDrug Des Devel Ther20092115122
   PubMedGoogle Scholar
• OgrisMWagnerETargeting tumors with non-viral gene delivery systemsDrug Discov Today2002747948511965397
   PubMed Web of Science ®Google Scholar
• McCruddenCMMcCarthyHOCancer gene therapy: key biological concepts in the design of multifunctional non-viral delivery systemsMolinaFGene Therapy: Tools and Potential ApplicationsLondonInTech2013213248
   Google Scholar
• GaoHJShiWDFreundLBMechanics of receptor-mediated endocytosisProc Natl Acad Sci U S A20051029469947415972807
   PubMed Web of Science ®Google Scholar
• Pérez-MartínezFCGuerraJPosadasICeñaVBarriers to non-viral vector-mediated gene delivery in the nervous systemPharm Res2011281843185821225319
   PubMed Web of Science ®Google Scholar
• TairaKKataokaKNiidomeTNon-Viral Gene Therapy: Gene Design and DeliveryHeidelbergSpringer2005
   Google Scholar
• MctaggartSAl-RubeaiMRetroviral vectors for human gene deliveryBiotechnol Adv20022013114538060
   PubMed Web of Science ®Google Scholar
• KamimuraKSudaTZhangGLiuDAdvances in gene delivery systemsPharmaceut Med20112529330622200988
   PubMedGoogle Scholar
• CurielDTDouglasJTCancer Gene TherapyTotowa (NJ)Humana Press2005
   Google Scholar
• ShanYLuoTPengCGene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectorsBiomaterials2012333025303522248990
   PubMed Web of Science ®Google Scholar
• AllenTMLiposomes: opportunities in drug deliveryDrugs199754814
   PubMed Web of Science ®Google Scholar
• FelgnerPLGadekTRHolmMLipofection: a highly efficient, lipid-mediated DNA-transfection procedureProc Natl Acad Sci U S A198784741374172823261
   PubMed Web of Science ®Google Scholar
• LongmireMChoykePLKobayashiHClearance properties of nanosized particles and molecules as imaging agents: considerations and caveatsNanomedicine (Lond)2008370371718817471
   PubMed Web of Science ®Google Scholar
• BendasGImmunoliposomes: a promising approach to targeting cancer therapyBiodrugs20011521522411437687
   PubMed Web of Science ®Google Scholar
• FasbenderAMarshallJMoningerTOGrunstTChengSWelshMJEffect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivoGene Ther199747167259282173
   PubMed Web of Science ®Google Scholar
• MastrobattistaEHenninkWEPolymers for gene delivery: charged for successNat Mater2012111012
   Web of Science ®Google Scholar
• MännistöMVanderkerkenSTonchevaVStructure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene deliveryJ Control Release20028316918212220848
   PubMed Web of Science ®Google Scholar
• LemkineGFDemeneixBAPolyethylenimines for in vivo gene deliveryCurr Opin Mol Ther2001317818211338931
   PubMed Web of Science ®Google Scholar
• BenjaminsenRVMattebjergMAHenriksenJRMoghimiSMAndresenTLThe possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pHMol Ther20132114915723032976
   PubMed Web of Science ®Google Scholar
• LynnDMLangerRDegradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNAJ Am Chem Soc20001221076110768
   Web of Science ®Google Scholar
• BuhleierEWehnerWVögtleF“Cascade”- and “nonskid-chain-like” syntheses of molecular cavity topologiesSynthesis19782155158
   Google Scholar
• TomaliaDABakerHDewaldJA new class of polymers: starburst-dendritic macromoleculesPolym J198517117132
   Web of Science ®Google Scholar
• KlajnertBBryszewskaMDendrimers: properties and applicationsActa Biochim Pol20014819920811440170
   PubMed Web of Science ®Google Scholar
• DufèsCUchegbuIFSchätzleinAGDendrimers in gene deliveryAdv Drug Deliv Rev2005572177220216310284
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• WallyJBuchananSKA structural comparison of human serum transferrin and human lactoferrinBiometals20072024926217216400
   PubMed Web of Science ®Google Scholar
• Al RobaianMChiamKYBlatchfordDRDufèsCTherapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomasNanomedicine (Lond)2014942143424910874
   PubMed Web of Science ®Google Scholar
• ShankaranarayananJSKanwarJRAl-JuhaishiAJKanwarRKDoxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in TRAMP miceSci Rep201663206227576789
   PubMed Web of Science ®Google Scholar
• AltwaijryNSomaniSParkinsonJARegression of prostate tumors after intravenous administration of lactoferrin-bearing polypro-pylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12Drug Deliv20182567968929493296
   PubMed Web of Science ®Google Scholar
• LiuZWangFChenXIntegrin αvβ3-targeted cancer therapyDrug Dev Res20086932933920628538
   PubMed Web of Science ®Google Scholar
• MarelliUKRechenmacherFSobahiTRMas-MorunoCKesslerHTumor targeting via integrin ligandsFront Oncol2013322224010121
   PubMedGoogle Scholar
• BonkhoffHSteinURembergerKDifferential expression of α6 and α2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligandsHum Pathol1993242432487681030
   PubMed Web of Science ®Google Scholar
• FornaroMManesTLanguinoLRIntegrins and prostate cancer metastasesCancer Metastasis Rev20012032133112085969
   PubMed Web of Science ®Google Scholar
• SuyinPCDickinsonJLHollowayAFIntegrins in prostate cancer invasion and metastasisHamiltonGAdvances in Prostate CancerRijeka, CroatiaInTech2013621639
   Google Scholar
• ZhengDQWoodardASFornaroMTalliniGLanguinoLRProstatic carcinoma cell migration via αvβ3 integrin is modulated by a focal adhesion kinase pathwayCancer Res1999591655166410197643
   PubMed Web of Science ®Google Scholar
• StachurskaAElbanowskiJKowalczyńskaHMRole of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditionsCell Biol Int20123688389222686483
   PubMed Web of Science ®Google Scholar
• HoroszewiczJSKawinskiEMurphyGPMonoclonal-antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic-cancer patientsAnticancer Res198779279362449118
   PubMed Web of Science ®Google Scholar
• KinoshitaYKuratsukuriKLandasSExpression of prostate-specific membrane antigen in normal and malignant human tissuesWorld J Surg20063062863616555021
   PubMed Web of Science ®Google Scholar
• ShenDXieFEdwardsWBEvaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA)PLoS One2013868339
   Web of Science ®Google Scholar
• DassieJPHernandezLIThomasGSTargeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigenMol Ther2014221910192224954476
   PubMed Web of Science ®Google Scholar
• GoodmanOBBarweSPRitterBInteraction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2Int J Oncol2007311199120317912448
   PubMed Web of Science ®Google Scholar
• LaidlerPDulińskaJLekkaMLekkiJExpression of prostate specific membrane antigen in androgen-independent prostate cancer cell line PC-3Arch Biochem Biophys200543511415680901
   PubMed Web of Science ®Google Scholar
• AggarwalSSinghPTopalogluOIsaacsJTDenmeadeSRA dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activityCancer Res2006669171917716982760
   PubMed Web of Science ®Google Scholar
• TaylorRMSevernsVBrownDCBisoffiMSillerudLOProstate cancer targeting motifs: expression of ανβ3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenograftsProstate20127252353221748756
   PubMed Web of Science ®Google Scholar
• Garcia-HernandezMLGrayAHubbyBKlingerOJKastWMProstate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunityCancer Res20086886186918245488
   PubMed Web of Science ®Google Scholar
• SharifiNSalmaninejadAFerdosiSHER2 gene amplification in patients with prostate cancer: evaluating a CISH-based methodOncol Lett2016124651465828105172
   PubMed Web of Science ®Google Scholar
• RabiauNDechelottePGuyLImmunohistochemical staining of mucin 1 in prostate tissuesIn Vivo20092320320719414404
   PubMed Web of Science ®Google Scholar
• BooksteinRRioPMadreperlaSAPromoter deletion and loss of retinoblastoma gene expression in human prostate carcinomaProc Natl Acad Sci U S A199087776277662217208
   PubMed Web of Science ®Google Scholar
• MazharDWaxmanJGene therapy for prostate cancerBJU Int20049346546915008710
   PubMed Web of Science ®Google Scholar
• ShalevMThompsonTCKadmonDAyalaGKernenKMilesBJGene therapy for prostate cancerUrology20015781611164134
   PubMed Web of Science ®Google Scholar
• JiaLTChenSYYangAGCancer gene therapy targeting cellular apoptosis machineryCancer Treat Rev20123886887622800735
   PubMed Web of Science ®Google Scholar
• WalczakHDeath receptor-ligand systems in cancer, cell death, and inflammationCold Spring Harb Perspect Biol20135a00869823637280
   PubMed Web of Science ®Google Scholar
• WongRSApoptosis in cancer: from pathogenesis to treatmentJ Exp Clin Cancer Res2011308721943236
   PubMed Web of Science ®Google Scholar
• TütingTGambottoABaarJInterferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor modelsGene Ther19974105310609415311
   PubMed Web of Science ®Google Scholar
• WangCYMayoMWBaldwinASTNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κBScience19962747847878864119
   PubMed Web of Science ®Google Scholar
• van HorssenRten HagenTLEggermontAMTNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utilityOncologist20061139740816614236
   PubMed Web of Science ®Google Scholar
• ChopraDPMenardREJanuszewskiJMattinglyRRTNF-α-mediated apoptosis, in normal human prostate epithelial cells and tumor cell linesCancer Lett200420314515414732222
   PubMed Web of Science ®Google Scholar
• MauceriHJHannaNNWayneJDTumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculatureCancer Res199656431143148813113
   PubMed Web of Science ®Google Scholar
• TandleAHannaELorangDTumor vasculature-targeted delivery of tumor necrosis factor-αCancer200911512813919090007
   PubMed Web of Science ®Google Scholar
• ChungTDMauceriHJHallahanDETumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancerCancer Gene Ther199853443499917088
   PubMed Web of Science ®Google Scholar
• ShuklaSGuptaSSuppression of constitutive and tumor necrosis factor-induced nuclear factor (NF)-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-κB-responsive genesClin Cancer Res2004103169317815131058
   PubMed Web of Science ®Google Scholar
• ShiJChenJSerradjiNPMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathwayPLoS One20138e6113223593410
   PubMed Web of Science ®Google Scholar
• BarresiGTuccariGLactoferrin in benign hypertrophy and carcinomas of the prostatic glandVirchows Arch A Pathol Anat Histopathol198440359666202054
   PubMedGoogle Scholar
• TuccariGBarresiGLactoferrin in human tumours: immunohistochemical investigations during more than 25 yearsBiometals20112477578421472415
   PubMed Web of Science ®Google Scholar
• AshkenaziAPaiRCFongSSafety and antitumor activity of recombinant soluble Apo2 ligandJ Clin Invest199910415516210411544
   PubMed Web of Science ®Google Scholar
• NorianLJamesBGriffithTAdvances in viral vector-based TRAIL gene therapy for cancerCancers2011360362024212631
   PubMedGoogle Scholar
• GriffithTStokesBKucabaTTRAIL gene therapy: from preclinical development to clinical applicationCurr Gene Ther2009991919275567
   PubMed Web of Science ®Google Scholar
• YuRMandlekarSRubenSNiJKongANTumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cellsCancer Res2000602384238910811114
   PubMed Web of Science ®Google Scholar
• FarooqiAAde RosaGTRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnologyAppl Microbiol Biotechnol2013978849885724037407
   PubMed Web of Science ®Google Scholar
• GriffithTSAndersonRDDavidsonBLWilliamsRDRatliffTLAdenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosisJ Immunol20001652886289410946322
   PubMed Web of Science ®Google Scholar
• LinTZhangLDavisJCombination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancersMol Ther2003844144812946317
   PubMed Web of Science ®Google Scholar
• SeolJYParkKHHwangCIAdenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effectCancer Gene Ther20031054054812833134
   PubMed Web of Science ®Google Scholar
• MohrAHendersonGDudusLAAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regressionGene Ther20041153454314999225
   PubMed Web of Science ®Google Scholar
• ChenZPenetMFKrishnamacharyBPSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancerBiomaterials201680576726706476
   PubMed Web of Science ®Google Scholar
• ElojeimySMckillopJCel-ZawahryAMFasL gene therapy: a new therapeutic modality for head and neck cancerCancer Gene Ther20061373974516543918
   PubMed Web of Science ®Google Scholar
• XiongLLiuYHZhangYPFas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacyClin Cancer Res2007135463547317875776
   PubMed Web of Science ®Google Scholar
• NakanishiHMazdaOSatohENonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivoGene Ther20031043444212601398
   PubMed Web of Science ®Google Scholar
• HyerMLSudarshanSSchwartzDAQuantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionCancer Gene Ther20031033033912679806
   PubMed Web of Science ®Google Scholar
• XiongLLiuYHZhangYPFas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacyClin Cancer Res2007135463547317875776
   PubMed Web of Science ®Google Scholar
• HedlundTEMeechSJSrikanthSAdenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cellsCell Death Differ1999617518210200564
   PubMed Web of Science ®Google Scholar
• Agha-MohammadiSLotzeMTImmunomodulation of cancer: potential use of selectively replicating agentsJ Clin Invest20001051173117610791989
   PubMed Web of Science ®Google Scholar
• MabjeeshNZhongHSimonsJWGene therapy of prostate cancer: current and future directionsEndocr Relat Cancer2002911513912121835
   PubMed Web of Science ®Google Scholar
• SharmaBMaWAdjeiIMNanoparticle-mediated p53 gene therapy for tumor inhibitionDrug Deliv Transl Res20111435222553503
   PubMed Web of Science ®Google Scholar
• SekiMIwakawaJChengHChengPWp53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategyHum Gene Ther20021376177311936974
   PubMed Web of Science ®Google Scholar
• BurdelskiCDieckmannTHeumannAp16 upregulation is linked to poor prognosis in ERG negative prostate cancerTumor Biology201637126551266327444279
   PubMedGoogle Scholar
• ShalevMThompsonTCKadmonDGene therapy for prostate cancerUrology20015781611164134
   PubMed Web of Science ®Google Scholar
• XiaoLJooKILimMWangPDendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in micePLoS One20127e4886623139820
   PubMed Web of Science ®Google Scholar
• MaurerTPournarasCAguilar-PimentelJAImmunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responsesUrol Oncol2013311395140121982682
   PubMed Web of Science ®Google Scholar
• MorrisJCRamlogan-SteelCAYuPVaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerGene Ther20142139340124572789
   PubMed Web of Science ®Google Scholar
• HullGWMccurdyMANasuYProstate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccinesClin Cancer Res200064101410911051263
   PubMed Web of Science ®Google Scholar
• CheeverMAHiganoCSProvenge (sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccineClin Cancer Res2011173520352621471425
   PubMed Web of Science ®Google Scholar
• GabagliaCDelaneyAGeeJTreatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of miceJ Transl Med201089820946663
   PubMed Web of Science ®Google Scholar
• FujitaTTimmeTLTabataKCooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancerGene Ther20071422723617024109
   PubMed Web of Science ®Google Scholar
• VargheseSRabkinSDLiuREnhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancersCancer Gene Ther20061325326516179929
   PubMed Web of Science ®Google Scholar
• NasuYBangmaCHHullGWCombination gene therapy with adenoviral vector-mediated HSV-tk + GCV and IL-12 in an orthotopic mouse model for prostate cancerProstate Cancer Prostatic Dis20014445512497062
   PubMed Web of Science ®Google Scholar
• LuYTranscriptionally regulated, prostate-targeted gene therapy for prostate cancerAdv Drug Deliv Rev20096157258819393705
   PubMed Web of Science ®Google Scholar
• KimKMWonYWAdhikaryPPHwangYMKimYHSuicidal gene therapy against tumor using reducible poly (oligo-d-arginine)J Control Release2011152e148e14922195813
   PubMed Web of Science ®Google Scholar
• ZarogoulidisPDarwicheKSakkasASuicide gene therapy for cancer: current strategiesJ Genet Syndr Gene Ther201341684924294541
   PubMedGoogle Scholar
• SatoTNeschadimALavieAYanagisawaTMedinJAThe engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancerPLoS One20138e7871124194950
   PubMed Web of Science ®Google Scholar
• YoshimuraIIkegamiSSuzukiSTadakumaTHayakawaMAdeno-virus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP systemJ Urol20021682659266412442005
   PubMed Web of Science ®Google Scholar
• YueQHHuXBYinYInhibition of prostate cancer by suicide gene targeting the FCY1 and HSV-TK genesOncol Rep2009221341134719885585
   PubMed Web of Science ®Google Scholar